Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Ambrx Biopharma Inc before investing.

In this article, we go over a few key elements for understanding Ambrx Biopharma Inc’s stock price such as:

• Ambrx Biopharma Inc’s current stock price and volume
• Why Ambrx Biopharma Inc’s stock price changed recently
• Upgrades and downgrades for AMAM from analysts
• AMAM’s stock price momentum as measured by its relative strength

About Ambrx Biopharma Inc (AMAM)

Before we jump into Ambrx Biopharma Inc’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Ambrx Biopharma Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing antibody drug conjugates (ADCs) and other engineered therapies to modulate the immune system. It is advancing a focused portfolio of clinical and preclinical programs designed to optimize efficacy and safety in multiple cancer indications, including ARX517, its antibody-drug conjugate (ADC) targeting the prostate-specific membrane antigen (PSMA) and ARX788, its ADC targeting Human epidermal growth factor receptor 2 (HER2). It uses genetic code technology platform to discover and develop engineered precision biologics. Its genetic code technology platform allows to incorporate, in a site-specific manner, synthetic amino acids (SAA), into proteins within living cells. Its SAA incorporation technology is designed to develop a range of product candidate modality, such as modified cytokines and bispecific antibodies, and others.

Want to learn more about Ambrx Biopharma Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Ambrx Biopharma Inc.

Ambrx Biopharma Inc’s Stock Price as of Market Close

As of November 15, 2023, 4:00 PM, CST, Ambrx Biopharma Inc’s stock price was $9.45.

Ambrx Biopharma Inc is up 4.88% from its previous closing price of $9.01.

During the last market session, Ambrx Biopharma Inc’s stock traded between $8.40 and $9.11. Currently, there are 391.28 million shares of Ambrx Biopharma Inc stock available for purchase.

Unfortunately, Ambrx Biopharma Inc’s P/E ratio is not significant enough to use for stock price evaluation. We recommend investors evaluate other financial metrics to understand its overall valuation.

Ambrx Biopharma Inc Stock Price History

Ambrx Biopharma Inc’s (AMAM) price is currently down 9.22% so far this month.

During the month of November, Ambrx Biopharma Inc’s stock price has reached a high of $11.59 and a low of $7.99.

Over the last year, Ambrx Biopharma Inc has hit prices as high as $16.86 and as low as $0.38. Year to date, Ambrx Biopharma Inc’s stock is up 4.65%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Ambrx Biopharma Inc Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of November 14, 2023, there was 1 analyst who downgraded Ambrx Biopharma Inc’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Ambrx Biopharma Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Ambrx Biopharma Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Ambrx Biopharma Inc (AMAM) by visiting AAII Stock Evaluator.

Relative Price Strength of Ambrx Biopharma Inc

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of November 14, 2023, Ambrx Biopharma Inc has a weighted four-quarter relative price strength of 152.16%, which translates to a Momentum Score of 100 and is considered to be Very Strong.

Want to learn more about how Ambrx Biopharma Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Ambrx Biopharma Inc Stock Price: Bottom Line

As of November 15, 2023, Ambrx Biopharma Inc’s stock price is $9.45, which is up 4.88% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Ambrx Biopharma Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.